abstract |
This invention relates to compounds of the formula (see formula I) wherein X, Y, R1 to R11 and n are as defined in the description, and all pharmaceutically acceptable enantiomers and salts and / or esters thereof. The invention also relates to pharmaceutical compositions containing such compounds, a process for their preparation and their use for the treatment and / or prevention of diseases that are modulated by PPAR (and / or PPAR agonists). |